Cost-effectiveness analysis of interferon-γ release assays versus chest X-ray for annual tuberculosis screening of healthcare workers

Journal of Hospital Infection

Volumn 78, Issue 2, 2011, Pages 152-154

  Kowada, A ^a   Deshpande, G A ^b,c   Takahashi, O ^b,d   Shimbo, T ^e   Fukui, T ^b,d  

^a Bunkyo City Public Health Center   (Japan)

^b St Luke's Life Science Institute   (Japan)

^c UNIVERSITY OF HAWAII   (United States)

^d ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOKINE RELEASE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERMETHOD COMPARISON; LATENT VIRUS INFECTION; LETTER; MALE; MASS SCREENING; NORMAL HUMAN; PROTEIN DETERMINATION; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; COST-BENEFIT ANALYSIS; HEALTH PERSONNEL; HUMANS; IMMUNOLOGIC TESTS; INCIDENCE; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MARKOV CHAINS; MASS CHEST X-RAY; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 79955969331     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.01.026     Document Type: Letter

References (8)

1. Menzies D., Joshi R., Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007, 11:593-605.
2. Schablon A., Harling M., Diel R., Nienhaus A. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis 2010, 30:107.
3. Schablon A., Beckmann G., Harling M., et al. Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases. J Occup Med Toxicol 2009, 4:1.
4. Seidler A., Nienhaus A., Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 2005, 72:431-446.
5. Mazurek M., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K. IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010, 25(RR-5):1-25.
6. Diel R., Loddenkemper R., Nienhaus A. Evidence-baced comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010, 137:952-968.
7. Berrington de González A., Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004, 363:345-351.
8. De Perio A., Tsevat J., Roselle G., et al. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med 2009, 169:179-187.